Proposals will add new apartments and specialist facilities at retirement village in grounds of grade I-listed Hampshire house

Grove Place thumbnail

Source: PRP

Grade I-listed Grove Place in Hampshire

PRP Architects has secured planning permission for a new care home in the grounds of grade I-listed Grove Place in Hampshire.

The former country house at Nursling, near Southampton, dates back to the mid-16th century and is at the centre of a retirement village run by LifeCare Residences.

Under the latest consent for the estate, Test Valley District Council has approved PRP’s plans for a development of 30 specialist nursing and dementia bedrooms, 20 close-care apartments, and new communal facilities including a café, lounges and a spa.

The practice said the development would complement the accommodation currently provided at Grove Place, which is more focused on independent living. Existing facilities include purpose-built apartments and bungalows, a restaurant, a bar, a pool and a gym.

PRP partner Jenny Buterchi said the design for the new care facility had been inspired by nearby stable buildings, while gable structures with chimney stacks were used to mark the entrance to the apartments and the care home wing.

“Grove Place is such a special place, a beautiful retirement village in Hampshire steeped in history with a grade I building at its heart,” she said.


Source: PRP

PRP’s proposals for new care facilities at grade I-listed Grove Place in Hampshire

“The proposed development will sensitively add to the historic setting with a stunning yet sympathetic contextual design.

“The expansion of Grove Place will provide some fantastic new amenities for both the existing and future residents whilst creating a more sustainable integrated retirement community able to provide the full continuum of care needs for its residents.”

Past owners of Grove Place include King Charles I and former prime minister Lord Palmerston. The building was used as a school for more than 40 years before it was acquired by LifeCare.


Source: PRP